Metraipolis › archive › dc_802e11d43947
Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository — Europe PMC PMID:32240266
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32240266
- DOI
- 10.1371/journal.pone.0231050
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T01:38:00.580Z
- SHA-256 of the archived text
4e03ee0aa59c0b4430469029218e2bf0e381fd0b03a1ff4ba148eb27c8af5b5d- Stable URL of this page
https://metraipolis.com/documento/dc_802e11d43947
How to cite
Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository — Europe PMC PMID:32240266 — Europe PMC (en), https://europepmc.org/article/MED/32240266 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_802e11d43947 (Metraipolis archive dc_802e11d43947, sha256 4e03ee0aa59c0b4430469029218e2bf0e381fd0b03a1ff4ba148eb27c8af5b5d)
BibTeX
@misc{dc802e11d43947,
title = {Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository — Europe PMC PMID:32240266},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32240266},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_802e11d43947; sha256 4e03ee0aa59c0b4430469029218e2bf0e381fd0b03a1ff4ba148eb27c8af5b5d},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32240266. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Newborn screening (NBS) aims to achieve early identification and treatment of affected infants prior to onset of symptoms. The timely completion of each step (i.e., specimen collection, transport, testing, result reporting), is critical for early diagnosis. Goals developed by the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) for NBS timeliness were adopted (time-critical results reported by five days of life, and non-time-critical results reported by day seven), and implemented into a multi-year quality improvement initiative (NewSTEPS 360) aimed to decrease the time to result reporting and intervention. Methods: The NBS system from specimen collection through reporting of results was assessed (bloodspot specimen collection, specimen shipping, sample testing, and result reporting). Annual data from 25 participating NBS programs were analyzed; the medians (and interquartile range, IQR) of state-specific percent of specimens that met the goal are presented. Results: The percent of specimens collected before 48 hours of life increased from 95% (88-97%) in 2016 to 97% (IQR 92-98%) in 2018 for the 25 states, with 20 (80%) of programs collecting more than 90% of the specimens within 48 hours of birth. Approximately 41% (IQR 29-57%) of specimens were transported within one day of collection. Time-critical result reporting in the first five days of life improved from 49% (IQR 26-74%) in 2016 to 64% (42%-71%) in 2018, and for non-time critical results from 64% (IQR 58%-78%) in 2016 to 81% (IQR 68-91%) in 2018. Laboratories open seven days a week in 2018 reported 95% of time-critical results within five days, compared to those open six days (62%), and five days (45%). Conclusion: NBS programs that participated in NewSTEPs 360 made great strides in improving timeliness; however, ongoing quality improvement efforts are needed in order to ensure all infants receive a timely diagnosis. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-04-02). Identificativi: PMID 32240266 · PMCID PMC7117765 · DOI 10.1371/journal.pone.0231050. Pagina: https://europepmc.org/article/MED/32240266 — https://doi.org/10.1371/journal.pone.0231050. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T01:34:41.352Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.